Illumina Researcher Outlines Strategy for Interpreting Clinical Information in Healthy Genomes
March 21, 2011
Illumina Researcher Outlines Strategy for Interpreting Clinical Information in Healthy Genomes
At the American College of Medical Genetics meeting this week, Illumina UK researcher Mark Ross described how researchers with the Illumina Clinical Services Laboratory are starting to interpret information from individual genome sequences.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Researchers Test Integrated Sequencing Strategy for Personalized Cancer Dx
November 30, 2011 / GenomeWeb Daily News - UMich Center to Offer Clinical Next-Gen Sequencing of Cancer Patients
August 31, 2011 / Clinical Sequencing News - TCGA Study Provides 'Roadmap' for Targeted Therapy, Genomic Subtyping in Ovarian Cancer
June 29, 2011 / Clinical Sequencing News - Exome Sequencing IDs Druggable BRAF Mutation in 47 HCL Patients
June 15, 2011 / Clinical Sequencing News - Mardis Outlines Use of Whole-Genome Analyses in Clinical Trials at AACR
April 5, 2011 / GenomeWeb Daily News